Fast circulation of cerebrospinal fluid: An alternative perspective on the protective role of high intracranial pressure in ocular hypertension

Clinical and Experimental Optometry

Volumn 99, Issue 3, 2016, Pages 213-218

  Wostyn, Peter ^a   De Groot, Veva ^b   Van Dam, Debby ^c   Audenaert, Kurt ^d   Killer, Hanspeter Esriel ^e   De Deyn, Peter Paul ^c,f,g  

^a PC Sint Amandus ^*  (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

^e CANTONAL HOSPITAL AARAU   (Switzerland)

^f MIDDELHEIM HOSPITAL   (Belgium)

^g UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Alzheimer's disease; Cerebrospinal fluid clearance; Glaucoma; Intracranial pressure; Ocular hypertension

Indexed keywords

AMYLOID BETA PROTEIN;

CEREBROSPINAL FLUID; GLAUCOMA; HUMAN; INTRACRANIAL PRESSURE; INTRAOCULAR HYPERTENSION; METABOLISM; OPTIC NERVE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA GANGLION CELL;

AMYLOID BETA-PEPTIDES; GLAUCOMA; HUMANS; INTRACRANIAL PRESSURE; OCULAR HYPERTENSION; OPTIC NERVE; RETINAL GANGLION CELLS;

EID: 84952360194     PISSN: 08164622     EISSN: 14440938     Source Type: Journal    
DOI: 10.1111/cxo.12332     Document Type: Review

References (52)

1. Berdahl JP, Allingham RR, Johnson DH. Cerebrospinal fluid pressure is decreased in primary open-angle glaucoma. Ophthalmology 2008; 115: 763-768.
2. Tamura H, Kawakami H, Kanamoto T, Kato T, Yokoyama T, Sasaki K, et al. High frequency of open-angle glaucoma in Japanese patients with Alzheimer's disease. J Neurol Sci 2006; 246: 79-83.
3. Yang Y, Yu M, Zhu J, Chen X, Liu X. Role of cerebrospinal fluid in glaucoma: Pressure and beyond. Med Hypotheses 2010; 74: 31-34.
4. Klein BE, Klein R, Sponsel WE, Franke T, Cantor LB, Martone J, et al. Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology 1992; 99: 1499-1504.
5. Bonomi L, Marchini G, Marraffa M, Bernardi P, De Franco I, Perfetti S, et al. Prevalence of glaucoma and intraocular pressure distribution in a defined population. The Egna-Neumarkt Study. Ophthalmology 1998; 105: 209-215.
6. Iwase A, Suzuki Y, Araie M, Yamamoto T, Abe H, Shirato S, et al. The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology 2004; 111: 1641-1648.
7. Pekmezci M, Vo B, Lim AK, Hirabayashi DR, Tanaka GH, Weinreb RN, et al. The characteristics of glaucoma in Japanese Americans. Arch Ophthalmol 2009; 127: 167-171.
8. Shiose Y, Kitazawa Y, Tsukahara S, Akamatsu T, Mizokami K, Futa R, et al. Epidemiology of glaucoma in Japan-a nationwide glaucoma survey. Jpn J Ophthalmol 1991; 35: 133-155.
9. Harada T, Harada C, Nakamura K, Quah HM, Okumura A, Namekata K, et al. The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma. J Clin Invest 2007; 117: 1763-1770.
10. Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002; 120: 701-713; discussion 829-830.
11. Berdahl JP, Allingham RR. Intracranial pressure and glaucoma. Curr Opin Ophthalmol 2010; 21: 106-111.
12. Wostyn P, Audenaert K, De Deyn PP. Alzheimer's disease-related changes in diseases characterized by elevation of intracranial or intraocular pressure. Clin Neurol Neurosurg 2008; 110: 101-109.
13. Berdahl JP, Fautsch MP, Stinnett SS, Allingham RR. Intracranial pressure in primary open angle glaucoma, normal tension glaucoma, and ocular hypertension: a case- control study. Invest Ophthalmol Vis Sci 2008; 49: 5412-5418.
14. Ren R, Jonas JB, Tian G, Zhen Y, Ma K, Li S, et al. Cerebrospinal fluid pressure in glaucoma: a prospective study. Ophthalmology 2010; 117: 259-266.
15. Ren R, Zhang X, Wang N, Li B, Tian G, Jonas JB. Cerebrospinal fluid pressure in ocular hypertension. Acta Ophthalmol 2011; 89: 142-148.
16. Hayreh SS. Cerebrospinal fluid pressure and glaucomatous optic disc cupping. Graefes Arch Clin Exp Ophthalmol 2009; 247: 721-724.
17. Hayreh SS. Cerebrospinal fluid pressure and glaucomatous optic disc cupping (response to Berdahl and colleagues). Graefes Arch Clin Exp Ophthalmol 2009; 247: 1291-1294.
18. Killer HE, Miller NR, Flammer J, Meyer P, Weinreb RN, Remonda L, et al. Cerebrospinal fluid exchange in the optic nerve in normal-tension glaucoma. Br J Ophthalmol 2012; 96: 544-548.
19. Fleischman D, Berdahl JP, Zaydlarova J, Stinnett S, Fautsch MP, Allingham RR. Cerebrospinal fluid pressure decreases with older age. PLoS One 2012; 7: e52664.
20. Wostyn P, De Groot V, Van Dam D, Audenaert K, De Deyn PP. Senescent changes in cerebrospinal fluid circulatory physiology and their role in the pathogenesis of normal-tension glaucoma. Am J Ophthalmol 2013; 156: 5-14.
21. Silverberg GD, Mayo M, Saul T, Rubenstein E, McGuire D. Alzheimer's disease, normal- pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis. Lancet Neurol 2003; 2: 506-511.
22. Killer HE, Jaggi GP, Flammer J, Miller NR, Huber AR. The optic nerve: a new window into cerebrospinal fluid composition? Brain 2006; 129: 1027-1030.
23. Killer HE, Laeng HR, Groscurth P. Lymphatic capillaries in the meninges of the human optic nerve. J Neuroophthalmol 1999; 19: 222-228.
24. Li J, Fang L, Killer HE, Flammer J, Meyer P, Neutzner A. Meningothelial cells as part of the central nervous system host defence. Biol Cell 2013; 105: 304-315.
25. Li J, Fang L, Meyer P, Killer HE, Flammer J, Neutzner A. Anti-inflammatory response following uptake of apoptotic bodies by meningothelial cells. J Neuroinflammation 2014; 11: 35.
26. Jaggi GP, Harlev M, Ziegler U, Dotan S, Miller NR, Killer HE. Cerebrospinal fluid segregation optic neuropathy: an experimental model and a hypothesis. Br J Ophthalmol 2010; 94: 1088-1093.
27. McKinnon SJ, Lehman DM, Kerrigan-Baumrind LA, Merges CA, Pease ME, Kerrigan DF, et al. Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest Ophthalmol Vis Sci 2002; 43: 1077-1087.
28. McKinnon SJ. Glaucoma: ocular Alzheimer's disease? Front Biosci 2003; 8: s1140-s1156.
29. Guo L, Salt TE, Luong V, Wood N, Cheung W, Maass A, et al. Targeting amyloid- beta in glaucoma treatment. Proc Natl Acad Sci U S A 2007; 104: 13444-13449.
30. Ito Y, Shimazawa M, Tsuruma K, Mayama C, Ishii K, Onoe H, et al. Induction of amyloid-β (1-42) in the retina and optic nerve head of chronic ocular hypertensive monkeys. Mol Vis 2012; 18:2647-2657.
31. Engelborghs S, De Vreese K, Van de Casteele T, Vanderstichele H, Van Everbroeck B, Cras P, et al. Diagnostic performance of a CSF- biomarker panel in autopsy-confirmed dementia. Neurobiol Aging 2008; 29: 1143-1159.
32. Yoneda S, Hara H, Hirata A, Fukushima M, Inomata Y, Tanihara H. Vitreous fluid levels of beta-amyloid((1-42)) and tau in patients with retinal diseases. Jpn J Ophthalmol 2005; 49: 106-108.
33. Silverberg GD, Mayo M, Saul T, Carvalho J, McGuire D. Novel ventriculo-peritoneal shunt in Alzheimer's disease cerebrospinal fluid biomarkers. Expert Rev Neurother 2004; 4: 97-107.
34. Wildsmith KR, Holley M, Savage JC, Skerrett R, Landreth GE. Evidence for impaired amyloid β clearance in Alzheimer's disease. Alzheimers Res Ther 2013; 5: 33.
35. Chiu C, Miller MC, Caralopoulos IN, Worden MS, Brinker T, Gordon ZN, et al. Temporal course of cerebrospinal fluid dynamics and amyloid accumulation in the aging rat brain from three to thirty months. Fluids Barriers CNS 2012; 9: 3.
36. Silverberg GD, Miller MC, Messier AA, Majmudar S, Machan JT, Donahue JE, et al. Amyloid deposition and influx transporter expression at the blood-brain barrier increase in normal aging. J Neuropathol Exp Neurol 2010; 69: 98-108.
37. Silverberg GD, Messier AA, Miller MC, Machan JT, Majmudar SS, Stopa EG, et al. Amyloid efflux transporter expression at the blood-brain barrier declines in normal aging. J Neuropathol Exp Neurol 2010; 69: 1034-1043.
38. Cuzzo LM, Ross-Cisneros FN, Yee KM, Wang MY, Sadun AA. Low-density lipoprotein receptor-related protein is decreased in optic neuropathy of Alzheimer disease. J Neuroophthalmol 2011; 31: 139-146.
39. Wang MY, Ross-Cisneros FN, Aggarwal D, Liang CY, Sadun AA. Receptor for advanced glycation end products is upregulated in optic neuropathy of Alzheimer's disease. Acta Neuropathol 2009; 118: 381-389.
40. Donahue JE, Flaherty SL, Johanson CE, Duncan JA 3rd, Silverberg GD, Miller MC, et al. RAGE, LRP-1 and amyloid-beta protein in Alzheimer's disease. Acta Neuropathol 2006; 112: 405-415.
41. Hayreh SS. Fluids in the anterior part of the optic nerve in health and disease. Surv Ophthalmol 1978; 23: 1-25.
42. Rodriguez-Peralta LA. Hematic and fluid barriers in the optic nerve. J Comp Neurol 1966; 126: 109-121.
43. Peyman GA, Apple D. Peroxidase diffusion processes in the optic nerve. Arch Ophthalmol 1972; 88: 650-654.
44. Tsukahara I, Yamashita H. An electron microscopic study on the blood-optic nerve and fluid-optic nerve barrier. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1975; 196: 239-246.
45. Hayreh SS. Optic disc edema in raised intracranial pressure. V. Pathogenesis. Arch Ophthalmol 1977; 95: 1553-1565.
46. Bayer AU, Ferrari F, Erb C. High occurrence rate of glaucoma among patients with Alzheimer's disease. Eur Neurol 2002; 47: 165-168.
47. Johanson CE, Duncan JA III, Klinge PM, Brinker T, Stopa EG, Silverberg GD. Multiplicity of cerebrospinal fluid functions: New challenges in health and disease. Cerebrospinal Fluid Res 2008; 5: 10.
48. Silverberg GD, Heit G, Huhn S, Jaffe RA, Chang SD, Bronte-Stewart H, et al. The cerebrospinal fluid production rate is reduced in dementia of the Alzheimer's type. Neurology 2001; 57: 1763-1766.
49. Serot JM, Zmudka J, Jouanny P. A possible role for CSF turnover and choroid plexus in the pathogenesis of late onset Alzheimer's disease. J Alzheimers Dis 2012; 30: 17-26.
50. Silverberg G, Mayo M, Saul T, Fellmann J, McGuire D. Elevated cerebrospinal fluid pressure in patients with Alzheimer's disease. Cerebrospinal Fluid Res 2006; 3: 7.
51. Wostyn P, Audenaert K, De Deyn PP. More advanced Alzheimer's disease may be associated with a decrease in cerebrospinal fluid pressure. Cerebrospinal Fluid Res 2009; 6: 14.
52. Fleischman D, Berdahl J, Stinnett SS, Fautsch MP, Allingham RR. Cerebrospinal fluid pressure trends in diseases associated with primary open-angle glaucoma. Acta Ophthalmol 2015; 93: e234-236.